| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S11936-002-0035-Z |
| P698 | PubMed publication ID | 11858777 |
| P2093 | author name string | Thomas D. Giles | |
| Gary E. Sander | |||
| P2860 | cites work | Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III) | Q27860959 |
| Cardiovascular thrombotic events in controlled, clinical trials of rofecoxib | Q28191367 | ||
| Association between antiphospholipid antibodies and cardiac abnormalities in patients with systemic lupus erythematosus | Q33393531 | ||
| Systemic lupus erythematosus: emerging concepts. Part 1: Renal, neuropsychiatric, cardiovascular, pulmonary, and hematologic disease | Q33489732 | ||
| Cardiac disease in systemic lupus erythematosus: prospective study of 70 patients | Q33567403 | ||
| Myocardial dysfunction in ankylosing spondylitis | Q33567466 | ||
| Cardiac involvement in rheumatoid arthritis. An echocardiographic study | Q33568774 | ||
| New and emerging therapies for collagen-vascular diseases | Q33811532 | ||
| New therapies for systemic lupus erythematosus | Q33893393 | ||
| How accelerated atherosclerosis in SLE has changed our management of the disorder | Q33915484 | ||
| Hormone replacement therapy in women with rheumatic diseases | Q33970317 | ||
| Risk of cardiovascular events associated with selective COX-2 inhibitors | Q34087109 | ||
| Cardiac involvement in rheumatoid disease. | Q34254088 | ||
| THE CARDIOVASCULAR MANIFESTATIONS OF SYSTEMIC LUPUS ERYTHEMATOSUS. | Q35456791 | ||
| Macrovascular disease and systemic sclerosis | Q35548842 | ||
| Inflammation-mediated rheumatic diseases and atherosclerosis | Q35549285 | ||
| Complete heart block in HLA B27 associated disease. Electrophysiological and clinical characteristics | Q36748062 | ||
| Systemic lupus erythematosus: a consideration for antimicrobial prophylaxis | Q39482499 | ||
| Serum lipoprotein(a) and apolipoprotein(a) phenotypes in patients with rheumatoid arthritis | Q74628456 | ||
| Cardiovascular autonomic nervous system dysfunction in patients with rheumatoid arthritis and systemic lupus erythematosus | Q77344801 | ||
| High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors | Q77406810 | ||
| Surgical management of cardiovascular lesions caused by systemic inflammatory diseases | Q77859305 | ||
| Prevalence and risk factors of carotid plaque in women with systemic lupus erythematosus | Q77909409 | ||
| The heart in systemic lupus erythematosus | Q79173569 | ||
| Rheumatoid heart disease. A study of the incidence and nature of cardiac lesions in rheumatoid arthritis | Q79363909 | ||
| Hormone replacement therapy and cardiovascular disease: a statement for healthcare professionals from the American Heart Association | Q95721603 | ||
| The electrocardiogram in systemic sclerosis (scleroderma). Study of 102 consecutive cases with functional correlations and review of the literature | Q39614635 | ||
| Clinically significant valvular heart disease in systemic lupus erythematosus | Q39616818 | ||
| Heart disease in patients with seropositive rheumatoid arthritis; a controlled autopsy study and review | Q39985494 | ||
| Cardiac involvement in scleroderma | Q41220227 | ||
| Premature morbidity from cardiovascular and cerebrovascular diseases in women with systemic lupus erythematosus | Q41608189 | ||
| HLA-B27-associated cardiac disease | Q41619011 | ||
| Association of antibodies against phospholipids with heart valve disease in systemic lupus erythematosus | Q41837002 | ||
| Risk factors for cardiovascular disease in systemic lupus erythematosus | Q43767819 | ||
| Myocardial lesions of progressive systemic sclerosis. A cause of cardiac dysfunction | Q44007356 | ||
| The heart in systemic lupus erythematosus and the changes induced in it by corticosteroid therapy. A study of 36 necropsy patients | Q44593960 | ||
| Cardiac abnormalities in systemic lupus erythematosus. Association with raised anticardiolipin antibodies | Q44728484 | ||
| Ultrasonic videodensitometric analysis in scleroderma heart disease | Q48581871 | ||
| Pathologic observations in systemic sclerosis (scleroderma). A study of fifty-eight autopsy cases and fifty-eight matched controls | Q49051672 | ||
| A comparison of cardiac valvular involvement in the primary antiphospholipid syndrome versus anticardiolipin-negative systemic lupus erythematosus. | Q51059360 | ||
| A tale of two diseases: atherosclerosis and rheumatoid arthritis. | Q54448410 | ||
| Prevalence and relation to risk factors of carotid atherosclerosis and left ventricular hypertrophy in systemic lupus erythematosus and antiphospholipid antibody syndrome | Q57219336 | ||
| Echocardiographic assessment of cardiac structure and function in patients with rheumatoid arthritis | Q67062997 | ||
| Systemic lupus erythematosus valve disease by transesophageal echocardiography and the role of antiphospholipid antibodies | Q67511161 | ||
| AIDS, lupus, rheumatoid arthritis--hypertension? | Q68408650 | ||
| Prevalence, Morphologic Types, and Evolution of Cardiac Valvular Disease in Systemic Lupus Erythematosus | Q68492546 | ||
| The effect of captopril on thallium 201 myocardial perfusion in systemic sclerosis | Q68504755 | ||
| Cardiac compression in rheumatoid pericarditis | Q68678494 | ||
| Cardiac involvement in systemic lupus erythematosus detected by echocardiography | Q68765065 | ||
| Nifedipine and thallium-201 myocardial perfusion in progressive systemic sclerosis | Q68797448 | ||
| De subitaneis mortibus. VIII. Coronary arteries and conduction system in scleroderma heart disease | Q68816625 | ||
| A controlled clinicopathologic study of myocardial fibrosis in systemic sclerosis (scleroderma) | Q68827931 | ||
| Doppler echocardiographic evaluation of left ventricular diastolic function in patients with systemic lupus erythematosus | Q68831355 | ||
| Cold-induced reversible myocardial ischaemia in systemic sclerosis | Q69373238 | ||
| Acute congestive heart failure due to the arteritis of rheumatoid arthritis: early diagnosis by endomyocardial biopsy: a case report | Q69562728 | ||
| Reversible cold-induced abnormalities in myocardial perfusion and function in systemic sclerosis | Q69634697 | ||
| The myocardium in ankylosing spondylitis. A clinical, echocardiographic, and histopathological study | Q69898419 | ||
| Cardiac and skeletal muscle disease in systemic sclerosis (scleroderma): a high risk association | Q70523026 | ||
| Cardiac conduction disturbances, an underestimated manifestation in ankylosing spondylitis. A 25-year follow-up study of 68 patients | Q70532418 | ||
| Thallium perfusion defects predict subsequent cardiac dysfunction in patients with systemic sclerosis | Q71077871 | ||
| Physiologic abnormalities of cardiac function in progressive systemic sclerosis with diffuse scleroderma | Q71252764 | ||
| Complete heart block in Reiter's syndrome | Q71286209 | ||
| Echo-Doppler left ventricular filling abnormalities in patients with rheumatoid arthritis without clinically evident cardiovascular disease | Q71328346 | ||
| Pathology of ankylosing spondylitis | Q71749904 | ||
| Comparison of the primary and secondary antiphospholipid syndrome: a European Multicenter Study of 114 patients | Q72764443 | ||
| [Patterns of ventricular late potentials in systemic sclerosis: a noninvasive method in the study of cardiac involvement] | Q72771388 | ||
| Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study | Q73106702 | ||
| The heart in rheumatoid arthritis | Q73117773 | ||
| Vascular events in hypertensive patients with systemic lupus erythematosus | Q73491948 | ||
| Autonomic dysfunction in systemic sclerosis: time and frequency domain 24 hour heart rate variability analysis | Q73543427 | ||
| Differential effects of aspirin and non-aspirin nonsteroidal antiinflammatory drugs in the primary prevention of myocardial infarction in postmenopausal women | Q73940124 | ||
| Noninvasive assessment of myocardial involvement in patients with systemic sclerosis: role of signal averaged electrocardiography | Q73987705 | ||
| Increased plasma levels of homocysteine and other thiol compounds in rheumatoid arthritis women | Q74601052 | ||
| Atherosclerosis, autoimmunity, and systemic lupus erythematosus | Q74623072 | ||
| P433 | issue | 2 | |
| P921 | main subject | vascular disease | Q1266890 |
| P304 | page(s) | 151-159 | |
| P577 | publication date | 2002-04-01 | |
| P1433 | published in | Current treatment options in cardiovascular medicine | Q27714743 |
| P1476 | title | Cardiovascular Complications of Collagen Vascular Disease | |
| P478 | volume | 4 |
| Q37190468 | Antigen-induced immunomodulation in the pathogenesis of atherosclerosis. | cites work | P2860 |
Search more.